51 /100
HIGH RISK
Score updated Jul 14, 2026

HCAC — Hall Chadwick Acquisition Corp. Dilution Risk Tracker

Track HCAC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HCAC — Get alerts when the score changes →

As of July 14, 2026, Hall Chadwick Acquisition Corp. (HCAC) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Hall Chadwick Acquisition Corp. has a market capitalization of $291.71M, 21.31M shares outstanding, 49 institutional holders tracked. Key dilution vectors include approximately 22 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HCAC.
🔔 Track HCAC — Get forecast alerts →

💹 Market Data

Market Cap$291.71M
Shares Outstanding21.31M
Float17.74M
Cash$350.2K
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

49 institutional holders · 17.95M shares
#1 METEORA CAPITAL, LLC 2.04M shares
#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 1.62M shares
#3 Verition Fund Management LLC 800.1K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.0K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for HCAC Shareholders

Hall Chadwick Acquisition Corp. (HCAC) has a DilutionScore of 51/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for HCAC shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HCAC in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HCAC alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HCAC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HCAC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HCAC
📊 HCAC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HCAC Signal Convergence & Dark Pool Activity — StonkWhisper 📄 HCAC Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.